1985
DOI: 10.1080/15287398509530688
|View full text |Cite
|
Sign up to set email alerts
|

Oral and intravenous trichloroethylene pharmacokinetics in the rat

Abstract: The pharmacokinetics of trichloroethylene (TCE) was studied in male Sprague-Dawley rats (300-350 g). TCE was administered intravenously and orally at doses of 5, 10, and 25 mg/kg to nonfasted rats and orally at 10 mg/kg to rats fasted for 8-10 h. The disappearance of TCE from the blood of intravenously dosed animals was best described by a two-compartment open pharmacokinetic model. The volume of the central compartment (Vc) approximated the rats' blood volume (50-70 ml/kg). The volume distribution (V beta) an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
10
0

Year Published

1990
1990
2023
2023

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 33 publications
2
10
0
Order By: Relevance
“…DISCUSSION TCE is a ubiquitous environmental pollutant in industrialized areas . It easily crosses the gastrointestinal wall and rapidly disappears from the blood , being ex haled unchanged or accumulated in tissues via the blood stream and metabolization (17,22,23). TCE is more rapidly metabolized than PECB or HCB, which were used in our previous studies (3)(4)(5)(6)(7).…”
Section: Resultsmentioning
confidence: 99%
“…DISCUSSION TCE is a ubiquitous environmental pollutant in industrialized areas . It easily crosses the gastrointestinal wall and rapidly disappears from the blood , being ex haled unchanged or accumulated in tissues via the blood stream and metabolization (17,22,23). TCE is more rapidly metabolized than PECB or HCB, which were used in our previous studies (3)(4)(5)(6)(7).…”
Section: Resultsmentioning
confidence: 99%
“…Most of the PBPK models for TRI have focused on the P450 metabolic pathway and have used the liver as the primary site of metabolism (Abbas and Fisher, 1997;Allen and Fisher, 1993;Dallas et al, 1991;D'Souza et al, 1985;Fisher, 2000;Fisher et al, 1991Fisher et al, , 1998Greenberg et al, 1999). While this approach accounts quantitatively for the majority of the metabolism and toxicity of TRI, it omits the GSH-dependent pathway and the kidney as a target organ.…”
Section: Discussionmentioning
confidence: 99%
“…Although the details of the metabolic pathways for TRI have been extensively studied and several physiologically-based pharmacokinetic (PBPK) models have been described for multiple species, including rats, mice, and humans (Abbas and Fisher, 1997;Allen and Fisher, 1993;Clewell et al, 2000;Dallas et al, 1991;D'Souza et al, 1985;Fisher, 2000;Fisher et al, 1991Fisher et al, , 1998Greenberg et al, 1999), questions remain concerning tissue levels of key metabolites after in vivo exposures to TRI and the relationship between P450-and GST-derived metabolites. Lipscomb et al (1998) developed parameters to correlate data on enzymatic rates and metabolite concentrations in vitro with those in vivo, although additional in vivo data are necessary for validation.…”
Section: Glutathione (Dcvg) S-(12-dichlorovinyl)-l-cysteine (Dcvc)mentioning
confidence: 99%
“…Prout et al (7) administered several doses of labeled TCE (10-2,000 mg/kg) to rats and mice and recovered 93-98% of the radiolabel and reported that peak blood levels occurred in 1 hr in mice and 3 hr in rats. D'Souza et al (14), using classical pharmacokinetic analysis, reported that oral and intravenous bioavailability of TCE was 60-90% in nonfasted rats and greater than 90% in fasted rats. Peak blood levels occurred between 6-10 min and blood concentrations were 2-3 times higher in the fasted rats compared with the nonfasted rats.…”
mentioning
confidence: 99%